Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\27931779
.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 Mol+Immunol
2017 ; 84
(ä): 57-64
Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Complement and sepsis-induced heart dysfunction
#MMPMID27931779
Fattahi F
; Ward PA
Mol Immunol
2017[Apr]; 84
(ä): 57-64
PMID27931779
show ga
It is well known that cardiac dysfunction develops during sepsis in both humans
and in rodents (rats, mice). These defects appear to be reversible, since after
"recovery" from sepsis, cardiac dysfunction disappears and the heart returns to
its function that was present before the onset of sepsis. Our studies, using in
vivo and in vitro models, have demonstrated that C5a and its receptors (C5aR1 and
C5aR2) play key roles in cardiac dysfunction developing during sepsis. Use of a
neutralizing antibody to C5a largely attenuates cardiac dysfunction and other
adverse events developing during sepsis. The molecular basis for cardiac
dysfunctions is linked to generation of C5a and its interaction with C5a
receptors present on surfaces of cardiomyocytes (CMs). It is established that C5a
interactions with C5a receptors leads to significant reductions involving faulty
contractility and relaxation in CMs. In addition, C5a interactions with C5a
receptors on CMs results in reductions in Na(+)/K(+)-ATPase in CMs. This ATPase
is essential for intact action potentials in CMs. The enzymatic activity and
protein for this ATPase were strikingly reduced in CMs during sepsis by unknown
mechanisms. In addition, C5a interactions with C5aRs also caused reductions in CM
homeostatic proteins that regulate cytosolic [Ca(2+)]i in CMs: sarco/endoplasmic
reticulum Ca(2+)-ATPase2 (SERCA2) and Na(+)/Ca(2+) exchanger (NCX). In the
absence of C5a receptors, defects in SERCA2 and NCX in CMs after sepsis are
strikingly attenuated. These observations suggest new strategies to protect the
heart from dysfunction developing during sepsis.